A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast

Clinical trial NCT00147238 · TERMINATED

Trial details

NCT number: NCT00147238
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Bladder Cancer Genitourinary Cancer Prostate Cancer

Start date: 2005-07-01
Primary completion: 2007-01-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.